1
|
Zhu L, Ye C, Chen S, Fang Y, Zhang Y, Zhang T. Rhodanine Derivatives Containing 5-Aryloxypyrazole Moiety as Anti-inflammatory and Anticancer Agents. Chem Biodivers 2024; 21:e202301844. [PMID: 38185756 DOI: 10.1002/cbdv.202301844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2023] [Revised: 01/05/2024] [Accepted: 01/05/2024] [Indexed: 01/09/2024]
Abstract
In this study, a series of rhodanine derivatives containing 5-aryloxypyrazole moiety were identified as potential agents with anti-inflammatory and anticancer properties. Most of the synthesized compounds demonstrated anti-inflammatory and anticancer activity. Notably, compound 7 g (94.1 %) exhibited significant anti-inflammatory activity compared with the reference drugs celecoxib (52.5 %) and hydrocortisone (79.4 %). Compound 7 g, at various concentrations, effectively inhibited nitric oxide (NO) production in a dose-dependent manner. Western blot results showed that compound 7 g could prevents LPS-induced expression of inflammatory mediators in macrophages. Enzyme-linked immunosorbent assay (ELISA) assay suggested that 7 g is a promising compound capable of blocking the downstream signaling of COX-2. In summary, these findings indicate that compound 7 g could be a promising candidate for further investigation.
Collapse
Affiliation(s)
- Lin Zhu
- Jilin Medical University, Jilin, Jilin, 132013, PR China
| | - Chao Ye
- Jilin Medical University, Jilin, Jilin, 132013, PR China
| | - Shuang Chen
- Jilin Medical University, Jilin, Jilin, 132013, PR China
| | - Yuqi Fang
- School of Life Sciences and Medicine, Shandong University of Technology, Zibo, Shandong, 255000, PR China
| | - Yu Zhang
- School of Life Sciences and Medicine, Shandong University of Technology, Zibo, Shandong, 255000, PR China
| | - Tianyi Zhang
- Jilin Medical University, Jilin, Jilin, 132013, PR China
| |
Collapse
|
2
|
Chaurasyia A, Chawla P, Monga V, Singh G. Rhodanine derivatives: An insight into the synthetic and medicinal perspectives as antimicrobial and antiviral agents. Chem Biol Drug Des 2023; 101:500-549. [PMID: 36447391 DOI: 10.1111/cbdd.14163] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2022] [Revised: 10/18/2022] [Accepted: 10/22/2022] [Indexed: 12/02/2022]
Abstract
Rhodanine or 2-Thioxothiazolidin-4-one is a privileged heterocyclic compound offering a wide opportunity for structural modification, lead development, and modification. It is one of the highly decorated scaffolds in the drug discovery process. Rhodanine derivatives possess a plethora of biological activities due to their ability to interact with a diverse range of protein targets, which provide tremendous opportunities to discover new drugs with different modes of action. The most common strategy for developing novel rhodanine derivatives is the introduction of structurally diverse substituents at the C-5 or N-3, or both positions. Since the inception of Epralestat into the market in 1992, the exploration of rhodanine-3-acetic acids has led to the development of novel leads against different biological targets such as MRSA, HHV-6, Mycobacterial tuberculosis, dengue, etc. In the current pandemic era, some rhodanine compounds have been explored against SARS-CoV-2. In recent years, rhodanine and its derivatives have witnessed significant progress in developing new drug leads as potential antimicrobial and antiviral agents. Different synthetic methodologies and recent developments in the medicinal chemistry of rhodanine derivatives, including biological activities, their mechanistic aspects, structure-activity relationships, and in silico findings, have been compiled in the present review. This article will benefit the scientific community and offer perspectives on how these scaffolds as privileged structures might be exploited in the future for rational design and discovery of rhodanine-based bio-active molecules.
Collapse
Affiliation(s)
- Abhishek Chaurasyia
- Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India
| | - Pooja Chawla
- Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India
| | - Vikramdeep Monga
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, India
| | - Gurpreet Singh
- Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India.,Research Scholar, IK Gujral Punjab Technical University, Kapurthala, Punjab, India
| |
Collapse
|
3
|
Upadhyay R, Khalifa Z, Patel D, Patel AB. Rhodanine‐Incorporated Indole Derivatives as Pharmacologically Vital Hybrids. ChemistrySelect 2022. [DOI: 10.1002/slct.202203896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
Affiliation(s)
- Rachana Upadhyay
- Department of Chemistry Government College Daman (Affiliated to Veer Narmad South Gujarat University Surat Daman (U.T.) 396210 India
| | - Zebabanu Khalifa
- Department of Chemistry Government College Daman (Affiliated to Veer Narmad South Gujarat University Surat Daman (U.T.) 396210 India
| | - Divyesh Patel
- Department of Chemistry Faculty of Science The Maharaja Sayajirao University of Baroda Vadodara 390002 India
| | - Amit B. Patel
- Department of Chemistry Government College Daman (Affiliated to Veer Narmad South Gujarat University Surat Daman (U.T.) 396210 India
| |
Collapse
|
4
|
Synthesis, Biological Evaluation and Molecular Docking Studies of 5-indolylmethylen-4-oxo-2-thioxothiazolidine Derivatives. Molecules 2022; 27:molecules27031068. [PMID: 35164333 PMCID: PMC8839324 DOI: 10.3390/molecules27031068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Revised: 01/31/2022] [Accepted: 01/31/2022] [Indexed: 11/17/2022] Open
Abstract
Background: Infectious diseases represent a significant global strain on public health security and impact on socio-economic stability all over the world. The increasing resistance to the current antimicrobial treatment has resulted in the crucial need for the discovery and development of novel entities for the infectious treatment with different modes of action that could target both sensitive and resistant strains. Methods: Compounds were synthesized using the classical organic chemistry methods. Prediction of biological activity spectra was carried out using PASS and PASS-based web applications. Pharmacophore modeling in LigandScout software was used for quantitative modeling of the antibacterial activity. Antimicrobial activity was evaluated using the microdilution method. AutoDock 4.2® software was used to elucidate probable bacterial and fungal molecular targets of the studied compounds. Results: All compounds exhibited better antibacterial potency than ampicillin against all bacteria tested. Three compounds were tested against resistant strains MRSA, P.aeruginosa and E.coli and were found to be more potent than MRSA than reference drugs. All compounds demonstrated a higher degree of antifungal activity than the reference drugs bifonazole (6–17-fold) and ketoconazole (13–52-fold). Three of the most active compounds could be considered for further development of the new, more potent antimicrobial agents. Conclusion: Compounds 5b (Z)-3-(3-hydroxyphenyl)-5-((1-methyl-1H-indol-3-yl)methylene)-2-thioxothiazolidin-4-one and 5g (Z)-3-[5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxo-thiazolidin-3-yl]-benzoic acid as well as 5h (Z)-3-(5-((5-methoxy-1H-indol-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)benzoic acid can be considered as lead compounds for further development of more potent and safe antibacterial and antifungal agents.
Collapse
|
5
|
Maruoka H, Masumoto E. Spiro Heterocycles: Synthesis and Application of Spiro Pyrazol-3-one Derivatives. HETEROCYCLES 2022. [DOI: 10.3987/rev-21-975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
6
|
Pyrazole-based analogs as potential antibacterial agents against methicillin-resistance staphylococcus aureus (MRSA) and its SAR elucidation. Eur J Med Chem 2020; 212:113134. [PMID: 33395624 DOI: 10.1016/j.ejmech.2020.113134] [Citation(s) in RCA: 76] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Revised: 12/07/2020] [Accepted: 12/22/2020] [Indexed: 01/01/2023]
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is becoming lethal to humanity due to easy transmission and difficult-to-treat skin and flimsy diseases. The most threatening aspect is the rapid resistance development of MRSA to any approved antibiotics, including vancomycin. The development of new, efficient, and nontoxic drug candidate to fight against MRSA isolates is the need of the hour. The intriguing molecular structure and versatile bioactive pyrazole core attracting to development required novel antibiotics. This review presents the decade developments of pyrazole-containing derivatives with a broad antibacterial movement against diverged bacterial strains. In specific, we correlated the efficacy of structurally diversified pyrazole analogs against MRSA and discussed different angles of structure-activity relationship (SAR). The current survey highlights pyrazole hybrids' present scenario on MRSA studies, covering articles published from 2011 to 2020. This collective information may become an excellent platform to plan and develop new pyrazole-based small MRSA growth inhibitors with minimal side effects.
Collapse
|
7
|
5-(1 H-Indol-3-ylmethylene)-4-oxo-2-thioxothiazolidin-3-yl)alkancarboxylic Acids as Antimicrobial Agents: Synthesis, Biological Evaluation, and Molecular Docking Studies. Molecules 2020; 25:molecules25081964. [PMID: 32340255 PMCID: PMC7221690 DOI: 10.3390/molecules25081964] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2020] [Revised: 04/21/2020] [Accepted: 04/21/2020] [Indexed: 12/11/2022] Open
Abstract
Background: Infectious diseases symbolize a global consequential strain on public health security and impact on the socio-economic stability all over the world. The increasing resistance to the current antimicrobial treatment has resulted in crucial need for the discovery and development of novel entity for the infectious treatment with different modes of action that could target both sensitive and resistant strains. Methods: Compounds were synthesized using classical methods of organic synthesis. Results: All 20 synthesized compounds showed antibacterial activity against eight Gram-positive and Gram-negative bacterial species. It should be mentioned that all compounds exhibited better antibacterial potency than ampicillin against all bacteria tested. Furthermore, 18 compounds appeared to be more potent than streptomycin against Staphylococcus aureus, Enterobacter cloacae, Pseudomonas aeruginosa, Listeria monocytogenes, and Escherichia coli. Three the most active compounds 4h, 5b, and 5g appeared to be more potent against MRSA than ampicillin, while streptomycin did not show any bactericidal activity. All three compounds displayed better activity also against resistant strains P. aeruginosa and E. coli than ampicillin. Furthermore, all compounds were able to inhibit biofilm formation 2- to 4-times more than both reference drugs. Compounds were evaluated also for their antifungal activity against eight species. The evaluation revealed that all compounds exhibited antifungal activity better than the reference drugs bifonazole and ketoconazole. Molecular docking studies on antibacterial and antifungal targets were performed in order to elucidate the mechanism of antibacterial activity of synthesized compounds. Conclusion: All tested compounds showed good antibacterial and antifungal activity better than that of reference drugs and three the most active compounds could consider as lead compounds for the development of new more potent agents.
Collapse
|
8
|
Synthesis and anti-leukemic activity of pyrrolidinedione-thiazolidinone hybrids. UKRAINIAN BIOCHEMICAL JOURNAL 2020. [DOI: 10.15407/ubj92.02.108] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
|
9
|
Zhang TY, Li CS, Cui MY, Bai XQ, Chen JH, Song ZW, Feng B, Liu XK. Design, synthesis and evaluation of dihydrotriazine derivatives-bearing 5-aryloxypyrazole moieties as antibacterial agents. Mol Divers 2020; 25:861-876. [PMID: 32172491 DOI: 10.1007/s11030-020-10071-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2019] [Accepted: 03/06/2020] [Indexed: 10/24/2022]
Abstract
In the present investigation, a series of dihydrotriazine derivatives-bearing 5-aryloxypyrazole moieties were synthesized and their structures were confirmed by different spectral tools. The biological evaluation in vitro revealed that some of the target compounds exerted good antibacterial and antifungal activity in comparison with the reference drugs. Among these novel hybrids, compound 10d showed the most potent activity with minimum inhibitory concentration values (MIC) of 0.5 µg/mL against S. aureus 4220, MRSA 3506 and E. coli 1924 strain. The cytotoxic activity of the compounds 6d, 6m, 10d and 10g was assessed in MCF-7 and HeLa cells. Growth kinetics study showed significant inhibition of bacterial growth when treated with different conc. of 10d. In vitro enzyme study implied that compound 10d exerted its antibacterial activity through DHFR inhibition. Moreover, significant inhibition of biofilm formation was observed in bacterial cells treated with MIC conc. of 10d as visualized by SEM micrographs. Twenty-nine target compounds were designed, synthesized and evaluated in terms of their antibacterial and antifungal activities.
Collapse
Affiliation(s)
- Tian-Yi Zhang
- Jilin Medical University, Jilin, 132013, People's Republic of China.
| | - Chun-Shi Li
- The Third People's Hospital of Dalian, Dalian, 116000, People's Republic of China
| | - Ming-Yue Cui
- The Third People's Hospital of Dalian, Dalian, 116000, People's Republic of China
| | - Xue-Qian Bai
- Jilin Medical University, Jilin, 132013, People's Republic of China
| | - Jiang-Hui Chen
- Jilin Medical University, Jilin, 132013, People's Republic of China.,Department of Pharmacy, Yanbian University, Yanji, 133002, People's Republic of China
| | - Ze-Wen Song
- Jilin Medical University, Jilin, 132013, People's Republic of China.,Department of Pharmacy, Yanbian University, Yanji, 133002, People's Republic of China
| | - Bo Feng
- Jilin Medical University, Jilin, 132013, People's Republic of China.
| | - Xue-Kun Liu
- School of Pharmacy Medicine, Tonghua Normal University, Tonghua, 134002, Jilin Province, People's Republic of China.
| |
Collapse
|
10
|
Abstract
In the last few decades, pyrazole chemistry has attracted chemists’ and biologists’ attention
mainly due to the discovery of the interesting properties of a great number of pyrazole derivatives.
The resulting proliferation of research literature reflects the enormous biological potential of
pyrazole derivatives as antitumor, anti-inflammatory, anti-HIV and antimicrobial agents. This review
focuses on research concerning the antimicrobial activity of pyrazole derivatives conducted from
2010-2018, and is intended to assist in the development of a new generation of antimicrobial drugs.
Collapse
Affiliation(s)
- Anshul Bansal
- Department of Chemistry, S. A. Jain (PG) College, Ambala City-134003, India
| |
Collapse
|
11
|
Maddila S, Gorle S, Jonnalagadda SB. Drug screening of rhodanine derivatives for antibacterial activity. Expert Opin Drug Discov 2019; 15:203-229. [PMID: 31777321 DOI: 10.1080/17460441.2020.1696768] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Introduction: Bacteriological infections are a major risk to human health. These include all hospital and public-acquired infections. In drug discovery, rhodanines are privileged heterocyclic frameworks. Their derivatives possess strong anti-bacterial activity and some of them have shown potent activity against multidrug-resistant pathogens, both under in vitro and in vivo conditions. To treat multi-drug resistant pathogens, the development of novel potent drugs, with superior anti-bacterial efficacy, is paramount. One avenue which shows promise is the design and development of novel rhodanines.Areas covered: This review summarizes the status on rhodanine-based derivatives and their anti-bacterial activity, based on published research over the past six years. Furthermore, to facilitate the design of novel derivatives with improved functions, their structure-activity relationships are assessed with reference to their efficacy as anti-bacterial agents and their toxicity.Expert opinion: The pharmacological activity of molecules bearing a rhodanine scaffold needs to be very critically assessed in spite of considerable information available from various biological evaluations. Although, some data on structure-activity relationship frameworks is available, information is not adequate to optimize the efficacy of rhodanine derivatives for different applications.
Collapse
Affiliation(s)
- Suresh Maddila
- School of Chemistry & Physics, University of KwaZulu-Natal, Westville Campus, Durban, South Africa.,Department of Chemistry, GITAM Institute of Sciences, GITAM University, Visakhapatnam, India
| | - Sridevi Gorle
- Department of Microbiology and Food Science & Technology, GITAM Institute of Sciences, GITAM University, Visakhapatnam, India
| | | |
Collapse
|
12
|
Mousavi SM, Zarei M, Hashemi SA, Babapoor A, Amani AM. A conceptual review of rhodanine: current applications of antiviral drugs, anticancer and antimicrobial activities. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 2019; 47:1132-1148. [DOI: 10.1080/21691401.2019.1573824] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- Seyyed Mojtaba Mousavi
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Maryam Zarei
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Seyyed Alireza Hashemi
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Aziz Babapoor
- Department of Chemical Engineering, University of Mohaghegh Ardabili, Ardabil, Iran
| | - Ali Mohammad Amani
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| |
Collapse
|
13
|
Da Silva CC, Martins RM, Lund RG, Pizzuti L, Pereira CMD. Recent Highlights on the Synthesis of Pyrazoles with Antimicrobial Activity. ACTA ACUST UNITED AC 2019. [DOI: 10.2174/1573407214666180730104941] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Background:
Heterocyclic compounds containing nitrogen atoms such as pyrazoles have a
long history and applicability in the field of medicinal chemistry. Many compounds containing pyrazole
moiety have been reported in the available literature for their prominent biological activities, including
antimicrobial activity against different microorganisms. Over the years, there has been a concern with
the many health problems associated with the dramatic increase of microbial infections and resistance to
standard drugs, so there is a need for the development of more effective antimicrobial agents. Pyrazoles
and their derivatives are promising candidates to bypass these problems with good safety profiles, and
there is a wide range of synthetic methodologies for their obtainment. This review aims to compact a
literature survey (2012-2017) very informative and helpful for researchers who wish to study or continue
the development of new, potent and broad-spectrum antimicrobial compounds.
Methods:
This review encompasses reports on the synthesis and antimicrobial evaluation of synthetic
pyrazoles from the year 2012 to 2017, which were extracted from bibliographic databases such as
PubMed, scielo, sciencedirect, scifinder, and scopus. The main keywords in our search were “pyrazole”
and “antimicrobial activity”, in which we made efforts to include synthetic and biological methodologies
that can be useful for laboratories of different levels of infrastructure. Moreover, inclusion/
exclusion criteria was applied to select quality reports which could demonstrate different tools of
antimicrobial evaluation, focusing on the advances made in the area, such as evaluation in silico and
exploration of the possible mechanism of action for active compounds.
Results:
Thirty-four papers were included in this work, which was displayed chronologically from the
year 2012 to 2017 in order to enhance the advances made in the area, with at least five reports from each
year. We found that the most commonly tested bacterial strains are Staphylococcus aureus, Escherichia
coli, Pseudomonas aeruginosa, Bacillus subtilis, and from the year 2016 onwards Mycobacterium tuberculosis.
The most common tested fungal strains are Candida albicans, Aspergillus flavus, and
Aspergillus niger. The majority of articles expressed the antimicrobial results as a zone of inhibition,
leading to the determination of the Minimum Inhibitory Concentration (MIC) and a probable mechanism
of action for the most prominent compounds, considering cytotoxicity. Aromatic aldehydes and
ketones are key reactants to obtain important precursors for the synthesis of pyrazoles, such as chalcones,
together with alkyl or phenylhydrazines and thiosemicarbazide. A great variation in the reported
MICs was found as there is no standard maximum limit, but many compounds exhibited antimicrobial
activity comparable or better than standard drugs, from which 10 reports active compounds with MIC
lower than 5 μg mL-1.
Conclusion:
The findings of this work support the importance of pyrazole moiety in the structure of
antimicrobial compounds and the versatility of synthetic methodologies to obtain the target products.
Results clearly indicate that they are attractive target compounds for new antimicrobial drugs development.
We hope that this information will guide further studies on continuing the search for more effective,
highly active antimicrobial agents.
Collapse
Affiliation(s)
- Caroline C. Da Silva
- Department of Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, RS, Brazil
| | - Rosiane M. Martins
- Postgraduate Program in Biotechnology, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Rafael G. Lund
- School of Dentistry, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Lucas Pizzuti
- Faculty of Exact Sciences and Technology, Federal University of Grande Dourados, Dourados, MS, Brazil
| | - Claudio M.P. de Pereira
- Department of Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, RS, Brazil
| |
Collapse
|
14
|
Maruoka H, Masumoto E, Nagabuchi H, Kashige N, Okabe-Nakahara F, Miake F, Yamagata K. Synthesis and DNA Cleavage Activity of Novel Spiro[cyclobutathiazole-4,4’-pyrazole] Derivatives. HETEROCYCLES 2019. [DOI: 10.3987/com-18-s(f)34] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
15
|
Trotsko N, Kosikowska U, Paneth A, Wujec M, Malm A. Synthesis and antibacterial activity of new (2,4-dioxothiazolidin-5-yl/ylidene)acetic acid derivatives with thiazolidine-2,4-dione, rhodanine and 2-thiohydantoin moieties. Saudi Pharm J 2018; 26:568-577. [PMID: 29844729 PMCID: PMC5961620 DOI: 10.1016/j.jsps.2018.01.016] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2017] [Accepted: 01/31/2018] [Indexed: 11/22/2022] Open
Abstract
A series of new (2,4-dioxothiazolidin-5-yl/ylidene)acetic acid derivatives with thiazolidine-2,4-dione, rhodanine and 2-thiohydantoin moiety (28–65) were synthesized by the reaction of (2,4-dioxothiazolidin-5-yl/ylidene)acetic acid chlorides with 5-(hydroxybenzylidene) thiazolidine-2,4-dione, rhodanine and 2-thiohydantoin derivatives. Obtained compounds (28–65) were tested on reference strains of Gram-positive bacteria and ones of the Gram-negative bacteria. The antibacterial activity of target compounds was determined by broth microdilution method. These derivatives showed antibacterial activity generally against Gram-positive bacterial strains. Most active compounds possess MIC = 3.91 mg/L. Our results suggest that presence of electron-withdrawing substituent at phenyl ring is favorable while geometry of molecule does not play important role in antibacterial response. It was confirmed the lack of direct influence of substitution pattern at phenyl ring on antibacterial activity of closely related compounds of series 1–3. The antibacterial activity of some compounds was similar or higher than the activity of commonly used reference drugs such as oxacillin and cefuroxime.
Collapse
Affiliation(s)
- Nazar Trotsko
- Department of Organic Chemistry, Faculty of Pharmacy with Medical Analytics Division, Medical University, 4A Chodźki, 20-093 Lublin, Poland
| | - Urszula Kosikowska
- Department of Pharmaceutical Microbiology with Laboratory for Microbiological Diagnostics, Faculty of Pharmacy with Medical Analytics Division, Medical University, 1 Chodźki, 20-093 Lublin, Poland
| | - Agata Paneth
- Department of Organic Chemistry, Faculty of Pharmacy with Medical Analytics Division, Medical University, 4A Chodźki, 20-093 Lublin, Poland
| | - Monika Wujec
- Department of Organic Chemistry, Faculty of Pharmacy with Medical Analytics Division, Medical University, 4A Chodźki, 20-093 Lublin, Poland
| | - Anna Malm
- Department of Pharmaceutical Microbiology with Laboratory for Microbiological Diagnostics, Faculty of Pharmacy with Medical Analytics Division, Medical University, 1 Chodźki, 20-093 Lublin, Poland
| |
Collapse
|
16
|
Kaminskyy D, Kryshchyshyn A, Lesyk R. 5-Ene-4-thiazolidinones - An efficient tool in medicinal chemistry. Eur J Med Chem 2017; 140:542-594. [PMID: 28987611 PMCID: PMC7111298 DOI: 10.1016/j.ejmech.2017.09.031] [Citation(s) in RCA: 100] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2017] [Revised: 07/14/2017] [Accepted: 09/17/2017] [Indexed: 02/02/2023]
Abstract
The presented review is an attempt to summarize a huge volume of data on 5-ene-4-thiazolidinones being a widely studied class of small molecules used in modern organic and medicinal chemistry. The manuscript covers approaches to the synthesis of 5-ene-4-thiazolidinone derivatives: modification of the C5 position of the basic core; synthesis of the target compounds in the one-pot or multistage reactions or transformation of other related heterocycles. The most prominent pharmacological profiles of 5-ene derivatives of different 4-thiazolidinone subtypes belonging to hit-, lead-compounds, drug-candidates and drugs as well as the most studied targets have been discussed. Currently target compounds (especially 5-en-rhodanines) are assigned as frequent hitters or pan-assay interference compounds (PAINS) within high-throughput screening campaigns. Nevertheless, the crucial impact of the presence/nature of C5 substituent (namely 5-ene) on the pharmacological effects of 5-ene-4-thiazolidinones was confirmed by the numerous listed findings from the original articles. The main directions for active 5-ene-4-thiazolidinones optimization have been shown: i) complication of the fragment in the C5 position; ii) introduction of the substituents in the N3 position (especially fragments with carboxylic group or its derivatives); iii) annealing in complex heterocyclic systems; iv) combination with other pharmacologically attractive fragments within hybrid pharmacophore approach. Moreover, the utilization of 5-ene-4-thiazolidinones in the synthesis of complex compounds with potent pharmacological application is described. The chemical transformations cover mainly the reactions which involve the exocyclic double bond in C5 position of the main core and correspond to the abovementioned direction of the 5-ene-4-thiazolidinone modification.
Collapse
Affiliation(s)
- Danylo Kaminskyy
- Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, Pekarska 69, Lviv-10, 79010, Ukraine
| | - Anna Kryshchyshyn
- Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, Pekarska 69, Lviv-10, 79010, Ukraine
| | - Roman Lesyk
- Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, Pekarska 69, Lviv-10, 79010, Ukraine.
| |
Collapse
|
17
|
Kaminskyy D, Kryshchyshyn A, Lesyk R. Recent developments with rhodanine as a scaffold for drug discovery. Expert Opin Drug Discov 2017; 12:1233-1252. [PMID: 29019278 DOI: 10.1080/17460441.2017.1388370] [Citation(s) in RCA: 67] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
INTRODUCTION Rhodanines, as one of the 4-thiazolidinones subtypes, are recognized as privileged heterocycles in medicinal chemistry. The main achievements include the development of drug-like molecules with numerous biological activities as well as approved drugs. Among rhodanines, 5-ene-rhodanines are of special interest, and are often claimed as pan assay interference compounds due to Michael acceptor functionality. Areas covered: Herein, the synthetic protocols for rhodanines and their transformation are reviewed. Biological activity is briefly discussed as well as biotargets, mode of actions and optimization directions. Furthermore, the utilization of 5-ene-rhodanines in Michael additions are discussed while both pro and contra arguments have been outlined within medicinal chemistry application. Expert opinion: Rhodanines remain privileged heterocycles in drug discovery. They are accessible building blocks for optimization and transformation into related heterocycles, simplified analogues and fused heterocycles with a thiazolidine framework. Michael acceptor functionality, as well as the thesis about low selectivity towards biotargets of rhodanines, must be confirmed experimentally and it cannot be based on just the presence of conjugated α,β-unsaturated carbonyl. Moreover, the positive aspects of Michael acceptors must be considered as well as their multitarget properties. New criteria for target affinity must be found. In conclusion, rhodanines are generally not problematic per se.
Collapse
Affiliation(s)
- Danylo Kaminskyy
- a Department of Pharmaceutical, Organic and Bioorganic Chemistry , Danylo Halytsky Lviv National Medical University , Lviv-10 , Ukraine
| | - Anna Kryshchyshyn
- a Department of Pharmaceutical, Organic and Bioorganic Chemistry , Danylo Halytsky Lviv National Medical University , Lviv-10 , Ukraine
| | - Roman Lesyk
- a Department of Pharmaceutical, Organic and Bioorganic Chemistry , Danylo Halytsky Lviv National Medical University , Lviv-10 , Ukraine
| |
Collapse
|
18
|
Song MX, Li SH, Peng JY, Guo TT, Xu WH, Xiong SF, Deng XQ. Synthesis and Bioactivity Evaluation of N-Arylsulfonylindole Analogs Bearing a Rhodanine Moiety as Antibacterial Agents. Molecules 2017; 22:molecules22060970. [PMID: 28613234 PMCID: PMC6152656 DOI: 10.3390/molecules22060970] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2017] [Revised: 06/06/2017] [Accepted: 06/09/2017] [Indexed: 12/18/2022] Open
Abstract
Due to the rapidly growing bacterial resistance to antibiotics and the scarcity of novel agents under development, bacterial infections are still a pressing global problem, making new types of antibacterial agents, which are effective both alone and in combination with traditional antibiotics, urgently needed. In this paper, seven series of N-arylsulfonylindole analogs 5–11 bearing rhodanine moieties were synthesized, characterized, and evaluated for antibacterial activity. According to the in vitro antimicrobial results, half of the synthesized compounds showed potent inhibition against four Gram-positive bacteria, with MIC values in the range of 0.5–8 µg/mL. For multidrug-resistant strains, compounds 6a and 6c were the most potent, with MIC values of 0.5 µg/mL, having comparable activity to gatifloxacin, moxiflocaxin and norfloxacin and being 128-fold more potent than oxacillin (MIC = 64 µg/mL) and 64-fold more active than penicillin (MIC = 32 µg/mL) against Staphylococcus aureusATCC 43300.
Collapse
Affiliation(s)
- Ming-Xia Song
- Basic Medical and Pharmacy College, Jinggangshan University, Ji'an 343009, Jiangxi, China.
| | - Song-Hui Li
- Basic Medical and Pharmacy College, Jinggangshan University, Ji'an 343009, Jiangxi, China.
| | - Jiao-Yang Peng
- Basic Medical and Pharmacy College, Jinggangshan University, Ji'an 343009, Jiangxi, China.
| | - Ting-Ting Guo
- Basic Medical and Pharmacy College, Jinggangshan University, Ji'an 343009, Jiangxi, China.
| | - Wen-Hui Xu
- Basic Medical and Pharmacy College, Jinggangshan University, Ji'an 343009, Jiangxi, China.
| | - Shao-Feng Xiong
- Basic Medical and Pharmacy College, Jinggangshan University, Ji'an 343009, Jiangxi, China.
| | - Xian-Qing Deng
- Basic Medical and Pharmacy College, Jinggangshan University, Ji'an 343009, Jiangxi, China.
| |
Collapse
|
19
|
Havrylyuk D, Roman O, Lesyk R. Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids. Eur J Med Chem 2016; 113:145-66. [PMID: 26922234 PMCID: PMC7115613 DOI: 10.1016/j.ejmech.2016.02.030] [Citation(s) in RCA: 75] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2015] [Revised: 02/10/2016] [Accepted: 02/11/2016] [Indexed: 11/28/2022]
Abstract
The features of the chemistry of 4-thiazolidinone and pyrazole/pyrazolines as pharmacologically attractive scaffolds were described in a number of reviews in which the main approaches to the synthesis of mentioned heterocycles and their biological activity were analyzed. However, the pyrazole/pyrazoline–thiazolidine-based hybrids as biologically active compounds is poorly discussed in the context of pharmacophore hybrid approach. Therefore, the purpose of this review is to summarize the data about the synthesis and modification of heterocyclic systems with thiazolidine and pyrazoline or pyrazole fragments in molecules as promising objects of modern bioorganic and medicinal chemistry. The description of biological activity was focused on SAR analysis and mechanistic insights of mentioned hybrids. Synthesis and chemistry of pyrazole/pyrazoline–thiazolidine-based hybrids. A diverse spectrum of pyrazole/pyrazoline–thiazolidine-based hybrids biological activities has been presented. Structure activity relationship of pyrazole/pyrazoline–thiazolidine-based hybrids for different activities has been discussed.
Collapse
Affiliation(s)
- Dmytro Havrylyuk
- Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, 69 Pekarska Street, Lviv, 79010, Ukraine; Department of Chemistry, University of Kentucky, 505 Rose Street, Lexington, KY 40506, United States
| | - Olexandra Roman
- Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, 69 Pekarska Street, Lviv, 79010, Ukraine
| | - Roman Lesyk
- Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, 69 Pekarska Street, Lviv, 79010, Ukraine.
| |
Collapse
|
20
|
Maqsood SR, Khan B, Bhat MA, Dar TA, Mir SH. Targeting copper induced oxidative damage to proteins by ligation: a novel approach towards chelation therapy for oxidative stress disorders. NEW J CHEM 2015. [DOI: 10.1039/c4nj02073a] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
DIDE and rhodanine prevent the copper induced oxidative damage to proteins by binding copper into a redox inactive state.
Collapse
Affiliation(s)
| | - Badruddin Khan
- Department of Chemistry
- University of Kashmir
- Srinagar-190006
- India
| | | | - Tanveer Ali Dar
- Department of Clinical Biochemistry
- University of Kashmir
- Srinagar-190006
- India
| | - Syed Hussain Mir
- Institute for Biochemistry and Molecular Biology
- University of Freiburg
- D-79104 Freiburg
- Germany
| |
Collapse
|
21
|
Song MX, Deng XQ, Li YR, Zheng CJ, Hong L, Piao HR. Synthesis and biological evaluation of (E)-1-(substituted)-3-phenylprop-2-en-1-ones bearing rhodanines as potent anti-microbial agents. J Enzyme Inhib Med Chem 2013; 29:647-53. [PMID: 24102526 DOI: 10.3109/14756366.2013.837899] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Herein, we report the design, syntheses and in vitro anti-microbial activity of two series of rhodanines with chalcone moiety. Anti-microbial tests showed that some of the synthesized compounds exhibited good inhibition (MIC = 1-8 µg/mL) against multi-drug-resistant Gram-positive organisms, including methicillin resistant and quinolone-resistant Staphylococcus aureus, in which the compound 4g was found to be the most potent with minimum inhibitory concentration (MIC) value of 1 µg/mL against two methicillin-resistant S. aureus.
Collapse
Affiliation(s)
- Ming-Xia Song
- Department of Pharmacy, Jing Gangshan University College of Medicine , Ji'an , People's Republic of China
| | | | | | | | | | | |
Collapse
|
22
|
Patel BA, Ashby CR, Hardej D, Talele TT. The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compounds. Bioorg Med Chem Lett 2013; 23:5523-7. [DOI: 10.1016/j.bmcl.2013.08.059] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2013] [Revised: 08/09/2013] [Accepted: 08/13/2013] [Indexed: 12/16/2022]
|
23
|
Lv HS, Ding XL, Zhao BX. Synthesis and X-ray Structure Characterisation of Novel Pyrazole Carboxamide Derivatives. JOURNAL OF CHEMICAL RESEARCH 2013. [DOI: 10.3184/174751913x13633729862156] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
A series of novel pyrazole carboxamide derivatives containing piperazine moiety was synthesised and determined by IR, 1H NMR and HRMS spectroscopy. Especially, the structure was confirmed by the X-ray crystal analysis of [1-(4- tert-butylbenzyl)-4-chloro-3-(4-chlorophenyl)-1 H-pyrazol-5-yl](4-phenylpiperazin-1-yl)methanone.
Collapse
Affiliation(s)
- Hong-Shui Lv
- Institute of Organic Chemistry, School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, P. R. China
| | - Xiao-Ling Ding
- College of Advanced Professional Technology, Qingdao University, Qingdao 266061, P. R. China
| | - Bao-Xiang Zhao
- Institute of Organic Chemistry, School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, P. R. China
| |
Collapse
|